Hematopoietic cell transplantation-specific comorbidity index to predict non-relapse mortality and survival after allografting.

被引：1
|
作者：
Kato, R [1 ]
Fukuda, T [1 ]
Usui, E [1 ]
Yamasaki, S [1 ]
Maruyama, D [1 ]
Morita, Y [1 ]
Kim, SW [1 ]
Mori, SI [1 ]
Tanosaki, R [1 ]
Tajima, K [1 ]
Heike, Y [1 ]
Makimoto, A [1 ]
Tobinai, K [1 ]
Takaue, Y [1 ]
机构：
[1] Natl Canc Ctr, Hematopoiet Cell Transplantat Unit, Tokyo, Japan
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.2731.2731
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2731
引用
收藏
页码：766A / 767A
页数：2
相关论文
共 50 条
  • [31] Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantation
    Schierbeck, Frederikke
    Mortensen, Jann
    Andersen, Niels S.
    Friis, Lone S.
    Kornblit, Brian
    Petersen, Soren L.
    Schjodt, Ida
    Sengelov, Henrik
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (01) : 50 - 59
  • [32] Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting
    Alessandro Busca
    Roberto Passera
    Enrico Maffini
    Moreno Festuccia
    Lucia Brunello
    Chiara Maria Dellacasa
    Semra Aydin
    Chiara Frairia
    Sara Manetta
    Sara Butera
    Giorgia Iovino
    Luisa Giaccone
    Mohamed Sorror
    Rainer Storb
    Francesco Giuseppe De Rosa
    Benedetto Bruno
    Bone Marrow Transplantation, 2018, 53 : 1304 - 1310
  • [33] Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantation
    Schierbeck, F.
    Andersen, N. S.
    Friis, L. S.
    Kornblit, B. T.
    Petersen, S. L.
    Schjodt, I.
    Sengelov, H.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 359 - 360
  • [34] Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting
    Busca, Alessandro
    Passera, Roberto
    Maffini, Enrico
    Festuccia, Moreno
    Brune, Lucia
    Dellacasa, Chiara Maria
    Aydin, Semra
    Frairia, Chiara
    Manetta, Sara
    Butera, Sara
    Iovino, Giorgia
    Giaccone, Luisa
    Sorror, Mohamed
    Storb, Rainer
    De Rosa, Francesco Giuseppe
    Bruno, Benedetto
    BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1304 - 1310
  • [35] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Masamitsu Yanada
    Naoyuki Uchida
    Tatsuo Ichinohe
    Takahiro Fukuda
    Junya Kanda
    Yoshinobu Kanda
    Yoshiko Atsuta
    Hideki Nakasone
    Bone Marrow Transplantation, 2021, 56 : 1720 - 1722
  • [36] Does one model fit all? Predicting non-relapse mortality after allogeneic hematopoietic cell transplantation
    Yanada, Masamitsu
    Uchida, Naoyuki
    Ichinohe, Tatsuo
    Fukuda, Takahiro
    Kanda, Junya
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Nakasone, Hideki
    BONE MARROW TRANSPLANTATION, 2021, 56 (07) : 1720 - 1722
  • [37] Treosulfan conditioning for allogenic hematopoietic stem cell transplantation in multiple myeloma, advantages for non-relapse mortality and survival, but with high incidence of relapse
    Gran, Charlotte
    Wang, Junfeng
    Nahi, Hareth
    Koster, Linda
    Einsele, Herman
    Itala-Remes, Maija
    Holler, Ernst
    Beelen, Dietrich
    Ciceri, Fabio
    Ehninger, Gerhard
    Finke, Juergen
    de Wreede, Liesbeth
    Ljungman, Per
    Tischer, Johanna
    Verbeek, Mareike
    Klyuchnikov, Evgeny
    Hilgendorf, Inken
    Schaefer-Eckart, Kerstin
    Scheid, Christof
    Bunjes, Donald
    Basara, Nadezda
    Haenel, Mathias
    Mueller, Lutz Peter
    Biersack, Harald
    Gahrton, Gosta
    Garderet, Laurent
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2018, 53 : 659 - 660
  • [38] It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
    Luft, Thomas
    Benner, Axel
    Jodele, Sonata
    Dandoy, Christopher E.
    Storb, Rainer F.
    Gooley, Ted A.
    Sandmaier, Brenda M.
    Radujkovic, Aleksandar
    Ho, Anthony D.
    Dreger, Peter
    Penack, Olaf
    BLOOD, 2016, 128 (22)
  • [39] Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study
    Michelis, F. V.
    Atenafu, E. G.
    Couban, S.
    Frazer, J.
    Shivakumar, S.
    Hogge, D. E.
    Toze, C. L.
    Rajkhan, W.
    Kim, H. J.
    Daly, A.
    Slaby, J.
    Finke, J.
    Kiss, T.
    Bredeson, C.
    Sabloff, M.
    Sheppard, D.
    Bakkar, M.
    Brune, M.
    Wall, D. A.
    Paulson, K.
    Popradi, G.
    Walker, I.
    Messner, H. A.
    BONE MARROW TRANSPLANTATION, 2016, 51 (07) : 1019 - 1021
  • [40] IMPACT OF REDUCTION IN GVHD-RELATED MORTALITY FOR RECENT IMPROVEMENT OF NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Kurosawa, S.
    Yakushijin, K.
    Yamaguchi, T.
    Atsuta, Y.
    Nagamura-Inoue, T.
    Akiyama, H.
    Taniguchi, S.
    Miyamura, K.
    Takahashi, S.
    Eto, T.
    Morishima, Y.
    Sakamaki, H.
    Fukuda, T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S288 - S289
12345